KMK
NEUTRALKromek Appoints New CFO as Paul Farquhar Retires
The technology company has appointed a new Chief Financial Officer as the current CFO retires.
Kromek Group
5.95GBX
-0.83%
Market Cap
38.17M
Volume
251.07k
21% of avg
P/E Ratio
-0.11
EPS (TTM)
-0.55
Beta
0.54
Day Range
5.82p - 6.20p
52 Week Range
4.30p5.95p9.50p
5.95p
Upcoming Events
1 January 2026
Potential extension of Supply Agreement with Siemens Healthineers
High Impact Event
FY 2026
Kromek expects to deliver revenue growth for the fifth consecutive year
High Impact Event
KMK
VERY GOODKromek Delivers Strong FY 2025 Results, Exceeding Expectations
The technology company has reported strong full-year results, with revenue and profits exceeding market expectations. The firm secured a major partnership and saw a significant improvement in its financial position.
KMK
GOODKromek Receives $25m Under Siemens Healthineers Agreement
The technology company has received the first $25m payment under a major agreement, enabling it to become profitable this year and providing a foundation for future growth.
KMK
NEUTRALKromek Group PLC Announces Change in Shareholding
The technology company announces a change in shareholding, with no significant implications for its business.
KMK
NEUTRALKromek Group Sees Increase in Major Shareholding
The technology company has seen an increase in major shareholding, but the announcement lacks details on the potential impact.
KMK
GOODKromek Signs Multi-Year Agreements with Siemens Healthineers, Expects Profitability This Year
The radiation detection technology firm has inked game-changing agreements with Siemens Healthineers, expecting to turn profitable this year. Despite current financial challenges, the deals promise to transform its balance sheet and future prospects.
KMK
VERY GOODKromek Secures Lucrative Agreements with Siemens Healthineers
The technology company has signed lucrative agreements with a major healthcare provider, expected to drive significant revenue growth and profitability in the current year.
KMK
NEUTRALKromek Group Announces AGM and Annual Report Publication
Routine regulatory update from a scientific instruments company, with no major news.
KMK
GOODKromek Group Reports Revenue Growth and Positive EBITDA in Annual Results
The radiation and bio-detection technology developer reported a 12% revenue increase and positive EBITDA, driven by strong demand in nuclear security and progress in medical imaging collaborations.
KMK
NEUTRALKromek Secures £4.9m Loan from Major Shareholder
The technology company has secured a £4.9m loan from a major shareholder, providing additional financing but lacking details on the firm's current performance.